文献速递流行病学与生物统计真实世界研究与卫生经济

主动通勤与心血管疾病、癌症及死亡风险的关联:前瞻性队列研究

Association between active commuting and incident cardiovascular disease, cancer, and mortality: prospective cohort study.
PubMed 文献 · BMJ · 2017-04-19

基于英国生物银行263450名参与者的前瞻性队列研究显示,在中位5.0年随访中,骑车通勤与心血管疾病、癌症及全因死亡风险降低相关,步行通勤与心血管疾病风险降低相关,但步行与全因死亡或癌症结局无统计学显著关联。

要点

  • 骑车通勤与全因死亡、癌症发病、癌症死亡、心血管疾病发病及死亡风险降低相关。
  • 步行通勤与心血管疾病发病及死亡风险降低相关,与全因死亡或癌症结局无统计学显著关联。
  • 包含骑车的混合通勤模式与全因死亡、癌症发病及癌症死亡风险降低相关。

核心结论

  • 骑车通勤与心血管疾病、癌症及全因死亡风险降低相关。
  • 步行通勤与心血管疾病风险降低相关,独立于主要测量混杂因素。
  • 鼓励和支持主动通勤的举措可降低死亡风险和重要慢性病负担。

研究设计与样本

  • 前瞻性人群研究,基于英国生物银行。
  • 纳入263450名参与者(女性106674名,占52%;平均年龄52.6岁),从英国22个站点招募。
  • 暴露变量为典型一天上下班通勤的交通方式(步行、骑车、混合模式对比非主动方式即汽车或公共交通)。

主要发现

  • 中位随访5.0年(四分位距4.3-5.5)期间,2430名参与者死亡(其中496例与心血管疾病相关,1126例与癌症相关),发生3748例癌症事件和1110例心血管疾病事件。
  • 最大调整模型中,骑车通勤与全因死亡风险降低相关(HR 0.59,95%CI 0.42-0.83,P=0.002),包含骑车的混合模式通勤为HR 0.76(95%CI 0.58-1.00,P<0.05)。
  • 骑车通勤与癌症发病风险降低相关(HR 0.55,95%CI 0.44-0.69,P<0.001),包含骑车的混合模式通勤为HR 0.64(95%CI 0.45-0.91,P=0.01)。
  • 骑车通勤与癌症死亡风险降低相关(HR 0.60,95%CI 0.40-0.90,P=0.01),包含骑车的混合模式通勤为HR 0.68(95%CI 0.57-0.81,P<0.001)。
  • 骑车通勤与心血管疾病发病风险降低相关(HR 0.54,95%CI 0.33-0.88,P=0.01),步行通勤为HR 0.73(95%CI 0.54-0.99,P=0.04);骑车通勤与心血管疾病死亡风险降低相关(HR 0.48,95%CI 0.25-0.92,P=0.03),步行通勤为HR 0.64(95%CI 0.45-0.91,P=0.01)。

关键数值与推荐

  • 步行通勤与全因死亡或癌症结局无统计学显著关联。
  • 包含步行的混合模式通勤与任何测量结局均无明显关联。

临床怎么用

  • 作者认为,鼓励和支持主动通勤的举措可降低死亡风险和重要慢性病负担。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective To investigate the association between active commuting and incident cardiovascular disease (CVD), cancer, and all cause mortality.Design Prospective population based study. Setting UK Biobank.Participants 263 450 participants (106 674 (52%) women; mean age 52.6), recruited from 22 sites across the UK. The exposure variable was the mode of transport used (walking, cycling, mixed mode v non-active (car or public transport)) to commute to and from work on a typical day.Main outcome measures Incident (fatal and non-fatal) CVD and cancer, and deaths from CVD, cancer, or any causes.Results 2430 participants died (496 were related to CVD and 1126 to cancer) over a median of 5.0 years (interquartile range 4.3-5.5) follow-up. There were 3748 cancer and 1110 CVD events. In maximally adjusted models, commuting by cycle and by mixed mode including cycling were associated with lower risk of all cause mortality (cycling hazard ratio 0.59, 95% confidence interval 0.42 to 0.83, P=0.002; mixed mode cycling 0.76, 0.58 to 1.00, P<0.05), cancer incidence (cycling 0.55, 0.44 to 0.69, P<0.001; mixed mode cycling 0.64, 0.45 to 0.91, P=0.01), and cancer mortality (cycling 0.60, 0.40 to 0.90, P=0.01; mixed mode cycling 0.68, 0.57 to 0.81, P<0.001). Commuting by cycling and walking were associated with a lower risk of CVD incidence (cycling 0.54, 0.33 to 0.88, P=0.01; walking 0.73, 0.54 to 0.99, P=0.04) and CVD mortality (cycling 0.48, 0.25 to 0.92, P=0.03; walking 0.64, 0.45 to 0.91, P=0.01). No statistically significant associations were observed for walking commuting and all cause mortality or cancer outcomes. Mixed mode commuting including walking was not noticeably associated with any of the measured outcomes.Conclusions Cycle commuting was associated with a lower risk of CVD, cancer, and all cause mortality. Walking commuting was associated with a lower risk of CVD independent of major measured confounding factors. Initiatives to encourage and support active commuting could reduce risk of death and the burden of important chronic conditions.

来源:BMJ,查看原文。版权归原作者所有。

引用

  1. Celis-Morales CA, Lyall DM, Welsh P, et al. Association between active commuting and incident cardiovascular disease, cancer, and mortality: prospective cohort study. BMJ. 2017. PMID: 28424154. doi:10.1136/bmj.j1456

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。